Irvine-based Edwards Lifesciences Corp.’s shares rose today after an announcement that it has acquired BMEYE B.V., a Dutch company, for $42 million.
The heart valve maker’s shares rose 4% to a market value of $10.2 billion in midday trading. They remain about 17% off for the week, reflecting a big drop on an earlier downgrade in the outlook for third-quarter sales,
BMEYE develops non-invasive advanced hemodynamic monitors that can be used in surgical, intensive care, emergency room and cardiology settings. The company’s monitors work with a finger cuff to measure patient information on cardiac output, blood pressure, fluid responsiveness and other parameters.
Edwards said it planned to further develop BMEYE’s technology and integrate it into its Edwards EV1000 monitoring platform for hospital use.
